Top 50 Medical Angel Investors in United Kingdom in January 2025

Investor	Medical United Kingdom investments
Jonathan Milner	12
Mark Bamforth	3
Ian Hogarth	3
Alexander Edward Chesterman	2
Jan Hruska	2
Matt Robinson	2
Matt Clifford	2
Nicholas Edwards	2
Will Martin	2
Taavet Hinrikus	2
Ariel Poler	2
Will Brooks	2
Michael Pennington	2
John Taysom	1
Phil Kirby	1
Adam Niewinski	1
Henry Engelhardt	1
Peer Schatz	1
Tracy Doree	1
Will Armitage	1
David Evans	1
Curtis Chambers	1
Brendan O'Driscoll	1
Catherine Lenson	1
Catherine Lenson	1
Evelyn Bourke	1
Robert Taub	1
Henry Carleton	1
Fred Moll, M.D	1
Jon Moulton	1
Arjun Desai	1
Mark McCamish	1
Mark Cuban	1
Imran Hakim	1
Michael Bibby	1
Nigel Rudd	1
Paul Thandi	1
Pa Nolan	1
Duncan Grierson	1
Jim Mellon	1
Nadav Rosenberg	1
Paul Roy	1
Manny Kadre	1
Yusuf Hamied	1
Sachin Agrawal	1
Brian Kennedy	1
Sidar Sahin	1
David Prior	1
Robert Marshall	1
Andrew MacKay	1

Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.

Investment focus

Biotechnology, Health Care, Medical
Seed, Series A, Series B
United Kingdom, United States, Canada

Portfolio highlights

Clock Bio — Clock Bio operates as a biotech company, that develops novel regenerative medicines.
Shift Bioscience — Explore cutting-edge simulation-guided cell rejuvenation techniques aimed at combating aging-related diseases.
Exciting Instruments — Exciting Instruments Limited is a joint company founded in Sheffield that combines the software prowess of Bulldozer Limited with Dr. Timothy Craggs' knowledge of single molecules. Through the use of cloud connectivity and real-time data visualisation, we are a genuine science and software partnership on a mission to assist you in streamliningthe procedure for creating discoveries in biophysics, life sciences, drug discovery, and medical diagnostics.

Mark Bamforth is the Operating Partner at Ampersand Capital Partners.

Investment focus

Health Care, Medical, Biotechnology
Series A, Seed, Funding Round
United Kingdom, United States

Portfolio highlights

Dxcover — Dxcover are a world leader in liquid biopsy and artificial intelligence for early detection of cancers and other diseases to improve survival and quality of life.
PneumoWave — Empowering Intervention and Prevention for Opioid-Induced Respiratory Depression
Thymmune Therapeutics — Thymmune Therapeutics is developing a machine learning-driven thymic cell engineering platform to restore normal immune function in aging and disease.

Ian got a master's in machine learning at Cambridge and loves dystopian robot takeover narratives. Seven years ago, Ian realized being a choirboy came with no street cred, so he started DJing hip-hop, funk, drum & bass, and grime. Ian quit his job at Bain & Company, Singapore to start Songkick.

Investment focus

Software, E-Commerce, Internet
Seed, Pre-Seed, Series A
United Kingdom, United States, Germany

Portfolio highlights

Claimer — Claimer is a self-service application that gets credit claims done easily of money spent on research and development. Its platform empowers company owners and advisors to prepare their claims, without any specialist knowledge, no matter how big or small the claim. It also prepares and submits the amended tax return for free.Claimer was founded in2019 by Adam McCann and is headquartered in Croydon, United Kingdom.
Unitary — We detect harmful content with context-aware AI to keep brands and platforms safe online.
Fabric — One home for your digital world. Your second brain. A file explorer and workspace for the internet age. All your drives, clouds, notes, screenshots, links, and files in one calm, minimal app. No organizing required. Never forget anything again.

Alex Chesterman is the Co-Founder of Houseful. Alex Chesterman attended the University College London.

Investment focus

E-Commerce, FinTech, Financial Services
Seed, Pre-Seed, Series A
United Kingdom, France

Portfolio highlights

Zefir — Zefir aims to expand the realm of possibilities for millions of European homeowners. We make home-selling simpler, faster and more certain by buying the property directly from you. Selling a home is now just a few clicks away.
Pharmacierge — Pharmacierge is the digital e-prescribing service chosen by private clinicians to deliver medication to their patients throughout the UK and worldwide. Clinicians create and transfer e-prescriptions to our pharmacy near London's Harley Street, for free delivery to their patients either the same day or next weekday
Vyne Technologies — Vyne Technologies is the specialist account-to-account payments platform.

Jan Hruska

Investment focus

Medical, Health Care, Life Science
Seed, Funding Round
United Kingdom

Portfolio highlights

Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.

Matt Robinson is the CEO and a co-founder at Nested, a property technology company. Prior to this, he founded GoCardless in 2010 and remains on the board of the recurring payment company.

Investment focus

Software, FinTech, Financial Services
Seed, Pre-Seed, Series A
United Kingdom, United States, Germany

Portfolio highlights

Malga — Malga is an online payment platform that offers fraud protection and payment split services.
Kaedim — Kaedim’s product creates 3D content as easily as you can take a photo, 2D content, with your smartphone today.
Feather — Feather gives you insurance advice for expats in Germany. Our digital insurance agent will help you get the right insurance policies for your need.

Matt co-founded EF after being a consultant at McKinsey & Co. Prior to EF Matt spent his time studying at MIT fuelled by an obsession with R, Python and unusual datasets. EF is the best place for Europe’s top technical individuals to meet and build world-changing startups in London.They select purely on the basis of technical talent, so youcan apply before you have a team or an idea. The intensive 6-month programme is designed to give you the best possible support in the first 200 days of your startup’s life.They have created over 40 startups now worth over $300 million. The startups are funded by some prestigious investors including Balderton Capital, Index Ventures, Octopus Investments and Y Combinator.

Investment focus

Software, FinTech, Artificial Intelligence
Seed, Pre-Seed, Funding Round
United Kingdom, India, United States

Portfolio highlights

Stackfix — Stackfix operates as a software comparison platform.
Patch — Patch is your new neighbourhood space for work, community, and events.
Flow Engineering — Requirements management, made collaborative

Nick serves as the Chairman of Prescient’s Board of Directors. He holds a degree in physiological sciences from The Queen’s College, University of Oxford, and completed his training in clinical medicine (BM, BCh) at Green College (now Green Templeton College), University of Oxford. Nick practiced in the areas of cardiology and general surgerybefore joining Andersen Consulting (now known as Accenture), eventually becoming the global leader of Accenture’s pharmaceutical R&D business during his 18-year tenure. In 2005, he founded Kinapse to provide consulting and outsourcing services to the pharmaceutical industry. Nick served as Kinapse’s Chairman until the company was sold to HgCapital in early 2016.

Investment focus

Medical, Health Care, Life Science
Seed, Funding Round
United Kingdom

Portfolio highlights

Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.

Will Martin - Founder and Director @ Portfolio Ventures

Investment focus

FinTech, Financial Services, Software
Seed, Funding Round, Series A
United Kingdom, United States

Portfolio highlights

Bequest — Digital estate planning made easy for professionals and individuals. Securely protect online accounts, cryptocurrencies, emails, media, documents and more.
Disputed — FinLegal is legaltech for the business of disputes. Our solutions allow you to fund and insure your litigation through litigation funding and after-the-event insurance, automate volume and class actions and get more clients through working with marketing service providers.
Robin AI — Robin AI is a legal tech company based in London, made up of engineers, lawyers, scientists and operations specialists.

Taavet Hinrikus is co-founder and CEO of TransferWise. Prior to starting TransferWise, Taavet was Skype’s director of strategy until 2008, starting as its first-ever employee. One of the World Economic Forum's Tech Pioneers, Taavet is an adviser to Prime Minister of Estonia on the digital agenda. He’s also a mentor and angel investor; hisinvestments include Tweetdeck, Mendeley, OMGPOP, Property Partner, Sunrise, Improbable and Mapillary.

Investment focus

FinTech, Software, Financial Services
Seed, Series A, Series B
United Kingdom, United States, Estonia

Portfolio highlights

Meatable — Meatable is a food production company that produces real and guilt-free meat. With one cell, they are revolutionizing the meat industry's impact on climate change and animal welfare. At the same time they increase food security, without compromising the culinary experience of eating tasty, real meat. They aim to satisfy the world'sappetite for meat without harming people, animals, and the planet.It was founded in 2018 and is headquartered in Delft, South Holland, The Netherlands.
Open Cosmos — Open Cosmos design, build and operate space missions, providing straightforward access to high quality satellite data and insights on a global scale.
Unearthly Materials — Unearthly Materials is a transformative materials company focused on delivering practical room-temperature superconductors and powering the century of superconductivity.

Ariel Poler is the Co-Founder of Reveri Health. Ariel is an Internet entrepreneur, mentor, and investor. He was the founder of IPRO, the first web analytics company, and of Topica, one of the first email communities. Ariel was a board member of Kana Software, LinkExchange, Odeo, LOLapps, and StumbleUpon. He currently serves on the boards of FreedomFinancial Network, MixTent, Strava, and Scan Inc. Ariel’s angel investments include AdMob, Flixster, Slideshare, Xobni, RockYou, and Outright, BrightRoll, Instructables, Causes, Kongregate and NexTag. Ariel holds a B.S. in Mathematics with Computer Science from MIT and an MBA from Stanford University. He is originally from Venezuela and lives in San Francisco with his wife and three children.

Investment focus

Software, Social Media, Internet
Seed, Series A, Angel
United States, Mexico, United Kingdom

Portfolio highlights

Reloadly — Unlock global access with Reloadly's powerful API for digital gift cards and mobile top- ups.Simplify payouts, boost engagement, and grow your business with customizable, easy- to - integrate solutions.
Openlytics — Openlytics is a visual analytics platform. It allows Data Workers to create pipelines for data transformation and analysis, in a visual way. Our mission is to empower everyone in the organization to solve data problems, without waiting for developers.Openlytics is an early-stage company, looking to build a founding team that can shape thedirection of the product. We’re seed-funded, remote-first, and hiring.If you're interested in learning more, email us at hello@openlytics.io.
humm — humm harnesses cutting-edge neuroscience into products that allow people to learn faster and perform better.humm is working to bring the incredible results of neuroscience research out of the lab and into non-invasive wearables that improve the quality of life for everyday people. Our first product is a clinically validated patch that you wearfor 15 minutes to get up to 90 minutes of improved working memory, by gently stimulating the signals in the part of the brain that controls your executive thinking. humm improves your ability to learn and be at your best, allowing people to reconnect with the joy of learning and challenge themselves to continue growing at any stage of life, whether it's for work or personal enjoyment!

Will Brooks - Founder & Director @ Portfolio Ventures

Investment focus

Financial Services, FinTech, Software
Seed, Funding Round, Series A
United Kingdom, United States

Portfolio highlights

Bequest — Digital estate planning made easy for professionals and individuals. Securely protect online accounts, cryptocurrencies, emails, media, documents and more.
Disputed — FinLegal is legaltech for the business of disputes. Our solutions allow you to fund and insure your litigation through litigation funding and after-the-event insurance, automate volume and class actions and get more clients through working with marketing service providers.
Robin AI — Robin AI is a legal tech company based in London, made up of engineers, lawyers, scientists and operations specialists.

One of the UK's leading tech angel investors. Active seed and pre-seed stage angel investor in UK based disruptive tech. Prefers businesses venturing into pastures new and keen investing at the pre product stage whether BtoC or B2B. Twice exited UK based tech entrepreneur with experience operating tech businesses in 20 countries in multiplelanguages. Co-founded Gumtree with Simon Crookall which was acquired by Ebay and Slando acquired by Naspers.

Investment focus

Software, SaaS, Financial Services
Seed, Pre-Seed, Funding Round
United Kingdom, United States, Spain

Portfolio highlights

Hubflo — Hubflo is building an all-in-one work OS to help small businesses manage their business. Instead of having 10 complicated and expensive pieces of software, Hubflo offers SMB everything they need to run their business (CRM, projects, invoicing, expenses...) in a single comprehensive, simple and affordable platform.
FUEL — Where everlasting fanbases are built
Sidekick — Expertly-managed portfolios for the modern investor

John Taysom started the Reuters Venture Capital Fund in Palo Alto in 1995 making 82 investments in internet and web infrastructure and services including Verisign, UltraDNS, Digimarc, ZeroKnowledge and Intertrust. He was a member of the Board of Digimarc pre and post its Nasdaq IPO, a Board member at Intertrust and a Board member at TIBCO throughits Nasdaq IPO. To date, seventeen of his investments have achieved an IPO.John acquired the Fund in an MBO in 2002. Now London-based with a seed portfolio of thirty US and UK start-ups; one has achieved an IPO and several have been acquired by Experian, Linkedin, Tesco, BMC and others.In 2011 and 2012 John took a Fellowship at Harvard to work on privacy issues and holds EU and US patents on a method of improving privacy online. For 2015 John is a Policy Fellow at the University of Cambridge Centre for Science and Policy and a Visiting Professor, Department of Computer Science, at UCL. He is a member of the Board of the Web Science Trust; chairs Performance Horizon, a fast growing UK startup; is a Governor at Hurstpierpoint College; and runs a small farm in Devon.

Investment focus

Software, Information Technology, Artificial Intelligence
Seed, Angel, Series A
United Kingdom, United States

Portfolio highlights

LGN — LGN's edge AI management software puts you in complete technical and financial control of your edge AI systems.
Tenyks — Tenyks gives Computer Vision Engineers the insights to build more reliable models faster! Collaborate to identify and fix dataset issues. Improve data quality. Boost model performance. No more wondering in the dark.
Worldr — Valarian | Innovating for the new era of digital sovereignty

Phil founded Health Intelligence in 1996 and maintains a vital role in the company shaping strategy and innovation. After graduating from Keele with an MBA on the Health Executive Programme, Phil spent thirteen years in the NHS as a senior manager responsible for I.T., registration and screening functions. This experience from within the NHS andprivate sector has given him an in-depth understanding of how cross sector population-based solutions can help the NHS overcome key challenges.

Investment focus

Medical, Hospital, Medical Device
Seed
United Kingdom

Portfolio highlights

AI-Sight — AI-Sight is a startup that is developing an AI diabetic retinal screening system to deliver WHO-recommended diabetic eye screening services.

Co-Founder and General Partner in OTB Ventures Graduated from the Warsaw School of Economics and is also Alumni of Stanford University - Graduate School of Business. Founder and CEO of Expander (Poland) as well as Co-Founder of Platinum Bank (Ukraine). Adam Niewiński started his professional career in 1997 at The Boston Consulting Group where heworked as a consultant specialized in financial services sector. As of 2000 he was building a team, acquired financing and subsequently established Expander, which became probably the first polish FinTech. Since 2002 up till 2017 had been associated with the UniCredit Group where he started working in the Central Brokerage House of Bank Pekao S.A. as Deputy CEO responsible for all business activities (investment banking and wealth management). Next, he became CEO of Xelion Investment House – a failed corporate start up that he successfully relaunched to become a leading platform for Personal Financial Advisers with $1b of AuA. In 2015 he was appointed Deputy CEO of Bank PEKAO SA responsible for Private Banking Division as well as Small and Mid Corpo acquisition and financing. He was also the Chairman of the Supervisory Board of Xelion Investment House, Chairman of the Supervisory Board of Private Equity Managers, Deputy Chairman of the Supervisory Board of Central Brokerage House of Bank Pekao S.A., Member of the Supervisory Board of Pekao Investment Banking, and Member of the Management Board of the Society for the Encouragement of Fine Arts by the Zachęta Gallery – National Gallery of Art.

Investment focus

FinTech, Financial Services, Artificial Intelligence
Series A, Seed, Funding Round
Poland, Singapore, United States

Portfolio highlights

ITaxi — ITaxi is a free mobile application, allowing its users to order cabs through its application. Its users do not have to know Polish to use the application as they can decide by type and model of the car, rate per kilometer, and time.ITaxi cooperates with local taxi federations and it has fleet of 10, 000 vehicles in over 100 cities all over thecountry, including Warsaw, Cracow, Lodz, Wroclaw, Gdansk, and Poznan. Launched in 2012 the application is based in Poland.
Credolab — An alternative credit scoring solution based on alternative data (smartphone and web metadata)
Audioteka — Audioteka is a mobile and multi-language audiobook application for smartphones/tablets with a dedicated audiobook car platform. They offer audiobooks in 9 languages in 23 countries.They strive to bring stories back into the lives of busy people through the creative use of technologies. They want everyone to try an audiobook at least once.They're confident you'll enjoy this new medium. People really can be smarter and better entertained thanks to their stories.They edit and produce audiobooks, collaborate with actors, inspire new and innovative productions and in doing so they offer unique content that can’t be found in any other audiobook store. Audioteka strives to give its customers the highest quality content via ready-to-use mobile solutions. They understand their mobile users and continue to learn from them every day. That is why they've created the world's most seamless platform for enjoying valuable spoken word content while on the go!

Henry Engelhardt

Investment focus

Health Care, SaaS, Brewing
Series A, Funding Round, Debt Financing
United States, Australia, United Kingdom

Portfolio highlights

Proximie — Proximie enables healthcare organizations, surgeons, and medical device companies to improve patient safety, scale training efforts, and accelerate device adoption, all while driving substantial savings in cost and time.
UZURV — UZURV is the Adaptive Transportation Network Company serving individuals with disabilities, the elderly, and non-emergency medical transportation needs. It's the efficiency and convenience of rideshare coupled with credentialed, drug and alcohol tested drivers for safe, reliable mobility for the transportation disadvantaged. Our AdaptiveTransportation Network Company (TNC) offers door-to-door service, certified drivers, and driver selection options that provide a high level of care and encourage greater understanding and security between riders and drivers. We be the ADA is more than just a law. It's a Promise and in Mobility Independence for All.
Drop Bear Beer — Drop Bear Beer specializes in creating revolutionary craft beers. The company was founded in 2018 and is headquartered in Swansea, Wales.

1989, Master's in Finance, Univ. of St Gallen, Switzerland; 1991, MBA in Finance, Graduate School of Business, Univ. of Chicago. Former: Partner, private management buy-out group, Switzerland; finance and systems positions, Sandoz and Computerland; finance, operations, management and sales positions, computer and software trading start-upcompanies, Europe, US. 1993, joined QIAGEN, when the company had just 30 employees and revenues of approximately $2 million. Former Member, German Corporate Governance Commission. Director: AdvaMedDx (US in-vitro diagnostics industry organization); ALDA (Analytical, Life Science & Diagnostics Association).

Investment focus

Medical, Genetics, Health Care
Seed
United States, United Kingdom

Portfolio highlights

Valar Labs — AI to Make Oncologists Smarter
Relation Therapeutics — Relation uses machine learning to develop drugs for pressing unmet need.

Tracy Dorée is a Founding Partner Kindred Capital. Tracy Dorée is the Co-Founder of Fab UK and serves as its Chief Executive Officer. She serves as Senior Vice President of Merchandising & Design for Europe at Fab, Inc. Tracy Dorée serves as an Investment Manager at MMC VENTURES Ltd. She joined MMC VENTURES in 2008 and is a Member of Investmentteam. Tracy Dorée is responsible for sourcing and executing new investments and managing individual portfolio companies. Prior to this, she gained experience in investment banking at NM Rothschild and strategy consulting at Accenture. Tracy Dorée served as Non-Executive Director of Base79 Limited. She holds a M.A. in Mathematics (first) from Balliol College, Oxford University.

Investment focus

FinTech, Medical, Wellness
Seed, Pre-Seed
United Kingdom

Portfolio highlights

Dishpatch — Dispatch is a finish-at-home meal kit platform that claims to bring the best of London’s ‘world-beating’ food scene to homes across the UK
Nosso — Nosso is a mobile-based financial planning platform for the future of children.
The Lowdown — 39K Followers, 1,214 Following, 723 Posts - See Instagram photos and videos from The Lowdown (@get.the.lowdown)

William Armitage is the Co-Founder & CFO ,Advisor of The Game Day.

Investment focus

FinTech, Software, Health Care
Seed, Angel, Pre-Seed
United Kingdom, Chile

Portfolio highlights

Global 66 — Global 66 is an international online payment platform that allows customers to transfer money with rates up.
Tallarium — Tallarium - The definitive pre-trade data and analytics platform for OTC energy markets, driven by data science
Alphagreen Group — Alphagreen Group is a global acquisition and incubation platform with a health & wellness focus. We help brands to scale via our own distribution channels and an extensive external omni-channel network. Build: We build brands using our marketplace and other sources to inform us on consumer demand. We automate the sales of products acrossvarious eCommerce channels, from DTC, on Alphagreen.io, Amazon, affiliates and other channelsAcquire: We acquire high calibre profitable health and wellness brands. We use our data and network to qualify existing products to forecast future growth and automate the management of assets once acquiredScale: We scale brands using our expertise in growth hacking, existing tech infrastructure and an experienced team. Distribution includes via DTC, alphagreen.io and external marketplaces such as Amazon.

Principal at Apax Digital.

Investment focus

Rental, Medical, Software
Series A, Series D, Series E
Israel, United Kingdom

Portfolio highlights

Guesty — Guesty simplifies the way property managers work.
MIP Diagnostics — MIP Diagnostics develop and manufacture molecularly imprinted polymers (nanoMIPs) that act as synthetic alternatives to antibodies for IVD and other industries.

Curtis Chambers

Investment focus

Internet, GPS, Marketplace
Seed, Series A, Pre-Seed
United States, United Kingdom

Portfolio highlights

Nana — Nana is a vertically integrated student-to-operator trade skills school, today focused on Appliance Repair. We work with some of the 35 million people who will lose their jobs by 2030 to tech automation, teaching them trade skills, building their experience through our mentorship program, and connecting them to good jobs on our marketplace. Byperfecting this pipeline and teaching life skills to a new generation of tradespeople, we are accelerating the retooling of America’s workforce and creating millions of economic opportunities.
TruckMap — The routing and revenue platform for truck drivers.
Juggle Jobs — We help professionals work flexibly

Brendan O'Driscoll is the Chief Product Officer of KOHO.

Investment focus

Health Care, Wellness, Artificial Intelligence
Seed, Pre-Seed, Series A
United States, India, United Kingdom

Portfolio highlights

Betterhalf — Best matrimony app in India with AI matchmaking. Get compatible life partner from lakhs of genuine, Govt ID and selfie verified profiles of brides & grooms. Download Betterhalf marriage app now!
Betty Labs — Spotify is a digital music service that gives you access to millions of songs.
Levels — Levels helps you see how food affects your health with data from biosensors like continuous glucose monitors (CGMs)

Catherine is an investor, board director and executive coach. She is based in London and works globally.She is an experienced international C-suite executive with a strong track record in the People, DE&I and ESG fields. Together with Jonathan Lenson. she invests in exceptional early-stage tech companies across the UK, US and Israel, andbrings in-depth previous board experience as both an executive and non-executive director.She writes and speaks on topics including the future of work, corporate culture and purpose, diversity and inclusion, and work/life integration.As part of her coaching practice, she is the first UK-based facilitator to be certified in the Fair Play method. Catherine was the first female Managing Partner appointed at SoftBank Investment Advisers, the world’s largest technology investment firm with $175 billion under management in the two SoftBank Vision Funds and SoftBank Latin America Funds. As the founding Chief People Officer for five years (2017-2022), she led the HR, ESG and Real Estate teams globally.An experienced and trusted executive coach at C-suite level, she worked with companies within the Vision Fund portfolio on leadership, talent, DE&I, ESG, and operating challenges, including as a Board Director.Catherine built SBIA’s ESG practice and designed its strategy for Social Impact. She led SoftBank’s early stage venture funds focused on diverse founders, including the $100m+ SB Opportunity Fund (US) and Emerge (EMEA), including as an Investment Committee member.Catherine is a Young Global Leader of the World Economic Forum (Class of 2021) and a founding member of Sustainability30 (which brings together Chief Sustainability Officers from 30 of the world’s leading companies).She spent the formative years of her career at UBS AG, Switzerland’s leading financial services firm, and is proud to have progressed from intern to Managing Director in the same firm. In her final role there, she led Reward for UBS across the UK and EMEA region.

Investment focus

Software, Information Technology, Internet
Seed, Pre-Seed, Grant
United Kingdom, Israel

Portfolio highlights

Fertifa — Fertifa is an innovative employer benefit solution making fertility care more accessible and affordable.The company works with employers to offer a valuable employee benefit which bridges the gap between an employer and their employees when dealing with the sensitivity and privacy of employees’ reproductive issues. It also offers guidance andadvice, next-generation fertility treatment, and access to a range of holistic services for the best chance of success. The company was founded in 2019 and based in London, United Kingdom.
Tangent — Tangent: Your bridge from diverse backgrounds to tech sales roles via referrals, coaching, and unique video pitches. Create a free account today!
Surfboard — Surfboard WFM features integrated forecasting, capacity planning, automated scheduling and performance analytics for modern support teams.

Catherine is an investor, board director and executive coach. She is based in London and works globally.She is an experienced international C-suite executive with a strong track record in the People, DE&I and ESG fields. Together with Jonathan Lenson. she invests in exceptional early-stage tech companies across the UK, US and Israel, andbrings in-depth previous board experience as both an executive and non-executive director.She writes and speaks on topics including the future of work, corporate culture and purpose, diversity and inclusion, and work/life integration.As part of her coaching practice, she is the first UK-based facilitator to be certified in the Fair Play method. Catherine was the first female Managing Partner appointed at SoftBank Investment Advisers, the world’s largest technology investment firm with $175 billion under management in the two SoftBank Vision Funds and SoftBank Latin America Funds. As the founding Chief People Officer for five years (2017-2022), she led the HR, ESG and Real Estate teams globally.An experienced and trusted executive coach at C-suite level, she worked with companies within the Vision Fund portfolio on leadership, talent, DE&I, ESG, and operating challenges, including as a Board Director.Catherine built SBIA’s ESG practice and designed its strategy for Social Impact. She led SoftBank’s early stage venture funds focused on diverse founders, including the $100m+ SB Opportunity Fund (US) and Emerge (EMEA), including as an Investment Committee member.Catherine is a Young Global Leader of the World Economic Forum (Class of 2021) and a founding member of Sustainability30 (which brings together Chief Sustainability Officers from 30 of the world’s leading companies).She spent the formative years of her career at UBS AG, Switzerland’s leading financial services firm, and is proud to have progressed from intern to Managing Director in the same firm. In her final role there, she led Reward for UBS across the UK and EMEA region.

Investment focus

Software, Information Technology, Internet
Seed, Pre-Seed, Grant
United Kingdom, Israel

Portfolio highlights

Fertifa — Fertifa is an innovative employer benefit solution making fertility care more accessible and affordable.The company works with employers to offer a valuable employee benefit which bridges the gap between an employer and their employees when dealing with the sensitivity and privacy of employees’ reproductive issues. It also offers guidance andadvice, next-generation fertility treatment, and access to a range of holistic services for the best chance of success. The company was founded in 2019 and based in London, United Kingdom.
Tangent — Tangent: Your bridge from diverse backgrounds to tech sales roles via referrals, coaching, and unique video pitches. Create a free account today!
Surfboard — Surfboard WFM features integrated forecasting, capacity planning, automated scheduling and performance analytics for modern support teams.

Evelyn was appointed Bupa’s Group CEO in July 2016, having been Acting Group CEO from April 2016. She is also a member of the Bupa Board and Nomination & Governance Committee.She has a strong track record in global executive management and extensive experience in financial services, risk and capital management, and mergers and acquisitions.Evelyn joined Bupa as CFO in September 2012, from Friends Life where she was Chief Executive Officer of its Heritage division. Previously at Friends Provident, she was the Executive Director responsible for strategy, capital and risk and, before that, Chief Financial Officer.Evelyn grew up on a dairy farm in Ireland and she’s the eldest of six. She was one of the first two women in Ireland to qualify as actuaries. She began her career with New Ireland Assurance and Bank of Ireland. She holds an MBA from London Business School and was previously a Non-Executive Director of the IFG Group in Ireland. Evelyn is currently a Non-Executive Director of the Bank of Ireland Group plc and a member of their Audit Committee and Nomination and Governance Committee.On becoming Group CEO in April 2016, Evelyn established a clear Strategic Framework to focus the organisation on delivering for customers.Evelyn believes strongly in promoting diversity in the workplace and empowering people to deliver high standards of service and care for customers.

Investment focus

InsurTech, Insurance, Software
Seed, Pre-Seed, Series B
United Kingdom

Portfolio highlights

Hybr — Find your next student accommodation with Hybr, the UK's best student letting platform. Over 5000 happy students served. Click to find your next property.
Lukango — Lukango takes care of your insurance so you can focus on growing your business, knowing your dream is protected in the right way.
Klarytee — Klarytee is a SaaS platform that builds security into sensitive content to enable granular control wherever the data goes

Robert Taub is the Co-Founder and Chairman at Nyxoah.

Investment focus

Biotechnology, Medical, Hospital
Funding Round, Series A, Series B
Israel, Belgium, United Kingdom

Portfolio highlights

LifeBond — LifeBond is a leader in the development and manufacturing of bio-surgical medical devices for tissue repair that are intended to improve the recovery of patients and to create an environment that supports the body’s natural healing process and promotes tissue repair. Of natural origin, elastic, adhesive, durable and yet absorbable, the company’sdevices can be used to fill a long list of unmet surgical needs. LifeBond’s first product, LifeSeal™, is designed to provide staple-line reinforcement in bariatric and colorectal operations. It was recently studied in an international pilot clinical study in Europe. The company’s second pipeline product, LifeMesh™, a self-fixating hernia mesh, is in pre-clinical development. Other pipeline products include tissue adhesives and absorbable hemostats. LifeSeal™, LifeMesh™ and other LifeBond™ products are investigational and have not yet been approved for sale in the US or in any other market. For more information please visit use at: www.life-bond.com
ARCHIMEDICX — RateCare is the easiest way to understand hospital quality. We rate, rank and benchmark hospitals with a scientific, unbiased method for important decisions. Our system is powered by a unique and HIMSS certified-unbiased algorithm developed by ARCHIMEDICX, which runs on one of the largest hospital procedural databases. Our data and tools areavailable for patients, hospitals and companies needing to make healthcare price/quality decisions. The RateCare team is dedicated to a patient-centric, transparent and sensible approach to measuring Hospital quality and pricing worldwide. Join us on www.ratecare.com
EyeD Pharma — We are EyeD Pharma, a clinical stage pharmaceutical company dedicated to improve the life of patients suffering from ophthalmic diseases.

Henry is a trained doctor with extensive hospital experience who co-founded Four Eyes Insight to put his talent for finding strategic solutions and planning into helping the NHS.His interest in medical resource management developed during his junior doctor training at Bart’s and the Royal London and he helped trusts tackle the significantchallenges of rotas and the New Deal as Junior Doctors’ Advisor at the London Regional Action Team.Establishing Zircadian Ltd, a software development company focusing on a portfolio of solutions to help NHS organisations plan and organise their medical workforce more strategically and effectively in 2000, he sold it on 11 years later to Allocate with over 140 NHS clients using its products.

Investment focus

Medical, Health Care, Health Diagnostics
Series A
United Kingdom

Portfolio highlights

Hexarad — Hexarad is a radiologist-led radiology company, which combines powerful tech and expert people to provide quick, accurate diagnoses. We have developed the Hexarad Platform, a unique and all-encompassing radiology solution powered by an intelligent allocative efficiency engine.

Frederic H. Moll, M.D. serves as Chief Development Officer of Johnson & Johnson’s Digital Surgery Group. Prior to Johnson & Johnson, Dr. Moll was CEO of Auris Health, Inc., located in Redwood City, California. Prior to Auris, Dr. Moll founded Hansen Medical and served as the company’s first CEO, and in 1995, founded Intuitive Surgical,Inc. (Nasdaq: ISRG).Dr. Moll earned a M.D. from the University of Washington, School of Medicine, a M.S. degree in Management from Stanford University’s Sloan Program, and a B.A. degree from the University of California at Berkeley.

Investment focus

Medical Device, Health Care, Medical
Seed, Series A, Angel
United States, United Kingdom, The Netherlands

Portfolio highlights

Mendaera — Mendaera enables all healthcare providers to perform precise and consistent point-of-care interventions. Their platform combines real-time imaging, robotics, and artificial intelligence to aid physicians in image acquisition and interpretation.
Bright Uro — Actionable Insight Improves Outcomes
Proclaim — Proclaim is a revolutionary, at-home, custom-jet oral irrigator that provides patients with the easiest, fastest, most effective at-home oral care.

Jon Moulton is a British venture capitalist. He is the founder and managing partner of the private equity firm Better Capital, and is the former managing partner of the private equity firm Alchemy Partners.

Investment focus

Financial Services, FinTech, Banking
Funding Round, Seed, Series A
United Kingdom, Cyprus, Luxembourg

Portfolio highlights

Pockit — Open a prepaid account in 3 minutes online or in-app, get your contactless prepaid card in 2 working days with no credit check.
Hometree — Keep yourself warm with Hometree, and try our no price hike promise. Compare our different boiler & home cover plans to see how you can save.
Hellas Direct — Hellas Direct is a digital-first, full-stack insurance company, empowered by cutting-edge technology and artificial intelligence. The Cyprus-based company is backed by a roster of leading investors, including Portag3, IFC (a member of the World Bank), Endeavor Catalyst, former Goldman Sachs economist Lord O’Neill and private equity veteran JonMoulton. Modelling itself on Amazon, Hellas Direct aims to disrupt the insurance value chain by adopting an extreme focus on operational excellence.

Dr. Desai brings a variety of medical industry, health policy, and clinical academic experiences to Avinger. Initially joining Avinger as a consultant in 2009, Dr. Desai helped to direct and publish the pivotal CONNECT study, which successfully established FDA clearance for Avinger’s Wildcat and Kittycat CTO crossing catheters. After joiningAvinger full time in 2012, Dr. Desai has expanded his focus to oversee health economics, reimbursement, clinical evidence generation, and scientific theory. In that time, Avinger has successfully published more than twenty manuscripts, clinical conference presentations, and case series. Most recently, Dr. Desai and his team successfully conducted and published the first ever peer reviewed Lumivascular manuscripts hallmarking a large European case series and the landmark CONNECT II clinical trial for the Ocelot catheter. Prior to Avinger, Dr. Desai served as a consultant and advisor for Incline Therapeutics, developing the IONSYS transdermal fentanyl delivery system. Additionally, Dr. Desai has consulted with pharmaceutical development targeting cancer therapeutics and healthcare IT development for capture of real time quality- metric assessment and implementation.Prior to management consulting, Dr. Desai served as a fellow in the US House Policy Committee, advising members of Congress on healthcare legislation. Additionally, Dr. Desai represented the US State Department and Rotary International as an Ambassador of Goodwill to Singapore where he led vaccine prophylaxis campaigns and lectured in the department of health economics at the National University of Singapore.Dr. Desai maintains his clinical practice as adjunct faculty at Stanford University in the department of Anesthesia where he completed his advanced anesthesia residency training. Dr. Desai holds an M.D. from the University of Miami Miller School of Medicine and a B.A. in Economics from the University of Oklahoma.

Investment focus

Medical, Health Care, Medical Device
Seed
United Kingdom

Portfolio highlights

TympaHealth — The award-winning Tympa system is designed to empower clinicians to deliver ear and hearing healthcare within local communities.

Dr. McCamish is President and Chief Executive Officer of IconOVir Bio. Previously he was President and Chief Executive Officer of Forty Seven, Inc. He led Forty Seven, Inc. during critical phases of clinical development to help patients defeat their cancer. This included growing from a valuation of $169 million as a private company through a SeriesB offering, Initial Public Offering, two secondary fund raises and finally the acquisition of Forty Seven by Gilead for $4.9 Billion.He is an international expert in biologic and biosimilars development and manufacturing. Mark is passionate about mentoring and developing people while focusing on meeting patient needs through efficient, commercially viable efforts. He is a senior executive with extensive experience at multiple companies including Abbott, Amgen, and Novartis/Sandoz. He led pioneering efforts in filing/launching biosimilars worldwide. He has demonstrated a commercial mindset in establishing research and development strategies leading to approvals and commercial success in multiple therapeutic areas and regulatory categories including biologics, biosimilars, drugs, devices, and medical foods.He received Bachelor’s and Master’s degrees from UCSB and, after completing his PhD in Human Nutrition from Penn State and MD from UCLA, he completed Residency and Fellowship Training at the University of California, Davis. He held professorships at UC Davis and The Ohio State University

Investment focus

Medical, Biopharma, Biotechnology
Seed
United Kingdom

Portfolio highlights

Nemesis Bioscience — Nemesis Bioscience is a UK-based biopharmaceutical company developing products to resurrect anti-microbial therapies made ineffective by increasing microbial resistance. The company develops Nemesis Symbiotics that will make existing antibiotics work again, prevent the spread of resistance genes, and so also protect the efficacy of new antibiotics.The technology is applicable to all antibiotic classes, all known resistance mechanisms and all bacteria.Other applications include reduction of chemotherapeutic toxicity, inactivation of virulence factors, and in vivo synthesis of biofuels and therapeutics.The company was awarded the King’s College, Cambridge Entrepreneurship Award for 2014 and has filed patent applications internationally on its inventions.

Mark Cuban is the founder of Fireside, Chairman and Founding Partner of AXS TV, and the Owner of Dallas Mavericks. He previously worked at Broadcast.com as a Co-Founder. Mark Cuban attended the Indiana University Bloomington.

Investment focus

Blockchain, Software, E-Commerce
Seed, Series A, Angel
United States, Vietnam, Singapore

Portfolio highlights

Bot-It — Online automation for everyone. Let Bot-It automatically complete your online tasks.
Allstar — Free, fast, and easy clip capture with zero FPS drop for Counter-Strike 2, League of Legends, Fortnite, and Dota 2.
Glove Wrap — Glove Wrap is a latex-free, thermoplastic elastomer band with the precise thickness, width, and length required to break in and shape your complete baseball glove while making the ideal pocket. Wrapping your glove with Glove Wrap applies pressure to the glove, reshaping it for easy use.

Imran Hakim, Optometrist, Inventor, and Serial Entrepreneur.

Investment focus

Medical, Health Care, Medical Device
Seed
United Kingdom

Portfolio highlights

TympaHealth — The award-winning Tympa system is designed to empower clinicians to deliver ear and hearing healthcare within local communities.

Michael Bibby is Chairman at Bibby Line Group Ltd.

Investment focus

Medical, Hospital, Medical Device
Seed
United Kingdom

Portfolio highlights

AI-Sight — AI-Sight is a startup that is developing an AI diabetic retinal screening system to deliver WHO-recommended diabetic eye screening services.

Sir Nigel Rudd is best known as founder of Williams plc in 1982, which went on to become one of the largest industrial holding companies in the United Kingdom until its demerger in November 2000, creating Chubb plc and Kidde plc. He is presently Chairman of BAA Limited and the technology company Invensys plc, and has been a long-term advocate of afund of this kind. Sir Nigel became Chairman of BGF in February 2011. Sir Nigel was knighted in 1996 for services to manufacturing. He has a long record as an active angel investor in small and medium-sized businesses. He has been Chairman of some of the largest companies in the UK, including Pilkington, Alliance Boots and the UK’s largest car retailer, Pendragon PLC, the company he founded with one dealership in 1982. He was a Director of Barclays PLC for 13 years, latterly as Deputy Chairman.

Investment focus

Health Care, Dental, Medical
Seed, Series A, Series B
United Kingdom

Portfolio highlights

Floe Oral Care — Quality oral care products that are kind to the planet. Designed by dentists and delivered straight to your door. Get started today.
Sky Medical Technology — Sky Medical Technology is a growth-stage bioelectronic medicine platform that completely redefines the way vascular related conditions are treated. The company has developed a neuromodulation therapy called OnPulse™, the first clinically proven bioelectronic compression technology to prevent and treat a wide range of acute and chronic circulatoryconditions. The first indications for the OnPulse wearable therapy are life threatening blood clots, swelling after orthopedic surgery, long term non-healing wounds, as well as applications for pro athletes to speed-up recovery time between games and during travel, conditions experienced by more than forty million people currently with unmet need.

Paul is the Founder and Chief Executive Officer of the NEC Group, the UK’s leading live events business, which owns; the NEC, ICC, Vox, Resorts World Arena, Utilita Arena Birmingham, The Ticket Factory and Amadeus.He was appointed Group CEO in 2006, bringing over 20 years’ experience in the media industry.Paul has since transformed the Groupinto a customer-centric and data-led organisation, whilst increasing its portfolio of businesses and venues, and leading the company through changes of ownership in 2015 and 2018.

Investment focus

Medical, Health Care, Medical Device
Seed
United Kingdom

Portfolio highlights

EDX Medical Group — EDX Medical Group provides innovative digital diagnostic products and services for cancer, cardiovascular disease, neurology, and infectious disease testing.

Pa Nolan

Investment focus

Medical, Delivery, Shipping
Seed, Funding Round
Ireland, United Kingdom

Portfolio highlights

SiSaf — SiSaf delivers on the promise of RNA therapeutics with Bio-Courier technology.
Scurri — Scurri is next generation delivery management software that puts retailers back in control. Explore our delivery management software today.

Duncan Grierson

Investment focus

Water, Medical, CleanTech
Seed, Series A
United Kingdom

Portfolio highlights

Puraffinity — Puraffinity develops targeted materials for water treatment, focused on forever chemicals called PFAS. Our strategic intent is to provide 1 billion people with PFAS safe water by 2030
Moixa Technology — Moixa Technology develops the Maslow intelligent energy storage solution, enabling homes to store energy and benefit from revenue streams generated by trading energy through GridShare, an SaaS platform that aggregates energy from groups of Maslow energy storage systems. . The company develops smart DC technologies to power DC lighting, computing,electronics from grid-shifted storage or local PV from smart DC hubs, variable DC networks and sockets. The technology and IPR reduces grid peak by shifting DC device load and powering DC devices efficiently without inverters or AC/DC adaptors, together with providing smart control and energy management. The technology aims to address the 1 trillion kwh + lost annually in power conversion, and the significant growing DC demand in homes, offices from ICT, LED lighting and the rise in internet connected devices.

Jim Mellon is an international investor with interests in several industries. After leaving Oxford, where he studied PPE, (Philosophy, Politics and Economics) he worked in Asia and the United States for two fund management companies, GT and Thornton, before establishing his own business in 1991. His business operations include two components, alisted fund management company called Charlemagne Capital, and an Asian mining group, Regent Pacific.In addition, Mr. Mellon is Co-Chairman of West African Minerals Corporation and Regent Pacific Group. He is on the board of a number of public quoted companies, including Brazilian Gold Corporation, Charlemagne Capital Limited, Manx Financial Group, Plethora Solutions, Polo Resources, Port Erin Biophara Investments Limited, and the Speymill plc. He is the life tenant of a trust which owns the Burnbrae Group, which has substantial assets in the biotechnology, financial services, property, mining and leisure sectors. Mr. Mellon spends most of his time working on startup ideas and investing. His book, “Wake Up!” was published in 2005; his second book "10 Investments for the Ten Years Ahead" was published in 2008. In 2012, he co-wrote "Cracking the Code" which focuses on the biotechnology sector and how to profit from it. Mr. Mellon lives in the Isle of Man, Brussels and Ibiza and is an honorary fellow of Oriel College, Oxford.

Investment focus

Biotechnology, Health Care, Food and Beverage
Series A, Seed, Funding Round
United States, United Kingdom, Israel

Portfolio highlights

Voxia — Amy collects and analyzes information from all over the web and provides actionable insights about your leads, prospects and clients, all in one click.
Monaco Foundry — We are a team of Serial Entrepreneurs, former Senior Government Advisors and Fortune 500 Executives. A global venture accelerator that invests in early to mid-stage companies and their growth through a unique sweat equity model.
The Duppy Share — The Duppy Share Caribbean Rum is the best rum for cocktails, mixed drinks and rum gifts. Try all our rum recipes, from rum and ginger to dark rum punch.

Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.

Investment focus

Biotechnology, Artificial Intelligence, Pharmaceutical
Seed, Pre-Seed, Series A
United Kingdom, Israel, Singapore

Portfolio highlights

thymia — Making mental health as objectively measurable as physical health.
Exogene — Exogene is a biotechnology company accelerating the discovery of T-cell-receptor(TCR)-based cancer immunotherapies for solid tumours by combining deep learning and high-throughput TCR-antigen screening. Exogene is building a computational platform to quickly and inexpensively identify new tumour targets shared across cancer patients, as well assafe and effective TCRs against these tumour targets for therapeutic application. Their mission is to develop better TCR-based immunotherapies, faster and at a fraction of the cost.
Loops — Loops is a no-code analytics platform that provides product and data teams with growth opportunities hidden in their data.

He was a founding partner and chairman of NewSmith Asset management, a fund manager for a wide range of institutional, pension fund and high net worth investors. Having started his career at the stockbroking firm Kemp Gee he subsequently became senior partner following the merger with Scrimgeour Vickers and Citibank. In 1988 he joined Smith Newcourt, the leading market making firm on the London Stock Exchange and as CEO, together with chairman Michael Marks merged the business with Merrill Lynch in 1995. At Merrill, Paul held a number of senior positions including head of Global Equities and in 2001 was made EVP and president of Merrill Lynch Global Markets and investment banking, responsible for the firm’s investment banking, debt and equity business worldwide. He left Merrill in 2003 to start NewSmith.He has served as a non executive director of Benfield plc and Cenkos securities and is currently Chairman of New River Retail plc the leading UK REIT specialising in retail property investment.Between 2007 and 2013 Paul served two terms as Chairman of the newly created British Horse Racing Authority, responsible for the Governance and Regulation of the country’s second largest sport. He is now Chairman of ROR, the sports main charity, responsible for ensuring that horses are cared for, retrained, and re-homed, after their racing careers are over. He has a Bachelor of Arts (Honours) degree in Economics from Liverpool University and in 2009 was awarded an Honoury Doctorate of Law from Liverpool University.

Investment focus

Fitness, Medical, Wellness
Seed
United Kingdom

Portfolio highlights

Qured — Get affordable and reliable PCR Fit to Fly tests and Antigen Fit to Fly tests from Qured. Fast results. Recommended by global airlines, UKAS accredited.

Manny Kadre

Investment focus

Medical, Health Care, Medical Device
Seed
United Kingdom

Portfolio highlights

TympaHealth — The award-winning Tympa system is designed to empower clinicians to deliver ear and hearing healthcare within local communities.

Yusuf Hamied is a Cambridge-educated Chemist and the Non-Executive Chairman of the Board of Directors at Cipla, a large generic pharmaceuticals company founded in 1935 by his father, Khwaja Abdul Hamied. Yusuf became a global celebrity for his role in defying Western multinational pharmaceutical companies in order to provide generic AIDS treatmentsand other drugs to treat poor people in the developing world. After completing his doctorate in 1960, Yusuf joined the family company and vowed to break the dominance of foreign multinationals over the Indian pharmaceutical market by developing cheap generic drugs. Yusuf helped persuade the Indian government to change Indian patent law in 1972, permitting medicines to be copied even if they were under international patent, as long as the process was not the same. The law transformed the Indian pharmaceutical industry, enabling his and other companies to grow by manufacturing generic drugs. In 2001 Yusuf convulsed the global healthcare industry by promising and then delivering a triple drug cocktail, Triomune, that helped fight against HIV and AIDS at prices far lower than those available internationally. Yusuf discusses his subsequent anger when, in 2005, the Indian government brought its patent laws in line with those of the developed world, prohibiting the copying of drugs patented after 1995 without a license and his resentment that he had thereafter “to go with a begging bowl to the multinationals” for licenses. This interview provides not only a personal perspective on how India’s third largest pharmaceutical firm was created, but contributes to the broad debates on the costs and benefits of intellectual property laws, particularly their impact on people who are denied life-saving drugs by their inability to pay for them. Working for Cipla as Managing Director for nearly 52 years, Yusuf was also the 28th richest Indian during one time. ‘CNN-IBN Indian of the year’ and one among the ’25 greatest global living legends’ were the titles that Yusuf won for his reign in the pharma world majorly for making medicines affordable to the poor. Yusuf was awarded with the civil honorary Padma Bhushan from then president APJ Abdul Kalam in the year 2005 for his fight against AIDS, which he often said was going to be as damaging to the society as a massive earthquake would be, if ignored. Yusuf earned his Bachelor's degree (1956), Master's degree (1957) and Ph.D. (1960) in Chemistry from University of Cambridge.

Investment focus

Medical, Medical Device
Seed
United Kingdom

Portfolio highlights

1inhaler — 1inhaler operates as a developer of drug delivery device.

Sachin Agrawal

Investment focus

Medical, Health Care, Health Diagnostics
Series A
United Kingdom

Portfolio highlights

Hexarad — Hexarad is a radiologist-led radiology company, which combines powerful tech and expert people to provide quick, accurate diagnoses. We have developed the Hexarad Platform, a unique and all-encompassing radiology solution powered by an intelligent allocative efficiency engine.

Brian Kennedy

Investment focus

Music, Medical, Commercial
Angel, Funding Round
United States, United Kingdom

Portfolio highlights

Gigmor — Booking live music has never been this easy!
Ryboquin — Ryboquin™ uses its expertise to turn under-developed intellectual property ideas into viable commercial realities. Founded in Scotland, Ryboquin Ltd is a privately held, virtual pharmaceutical company focused on commercialising patented technologies in the area of human cancer medicine.Founded in Scotland, Ryboquin is a privately held, virtualpharmaceutical company focused on commercializing patented technologies in the area of human cancer medicine.

Sidar Sahin is Founder & CEO at Peak Games.

Investment focus

Medical, mHealth, Health Care
Series A
United Kingdom

Portfolio highlights

Anima — Anima's online patient triage speeds up the clinical workflow 10x and allows providers to deliver the right care for patients within 24 hours.Millions of patients with serious problems are missed and die every year because there isn’t adequate information flow between medical appointments. Patients submit their problems and requests onAnimainstead of waiting for an appointment, and Anima sends an actionable report to their provider with trends, risks and recommendations.

David Prior is the former chair of the UK's National Health Service.

Investment focus

Health Care, Medical, Software
Seed
Belgium, United Kingdom

Portfolio highlights

TORTUS AI — Innovative medical AI which revolutionises the healthcare industry by enhancing clinical operations and patient care. Book a free demo today.
Awell Health — Ollie is a vast library of over 100 interface blocks with complete Webflow CMS integration. Build beautiful websites in less time than ever.

Robert Marshall is Executive Chairman of Martlet Capital.

Investment focus

Medical, Health Care, Medical Device
Seed
United Kingdom

Portfolio highlights

EDX Medical Group — EDX Medical Group provides innovative digital diagnostic products and services for cancer, cardiovascular disease, neurology, and infectious disease testing.

Andrew MacKay

Investment focus

Medical, Hospital, Health Care
Seed
United Kingdom

Portfolio highlights

MyHealthPal — MyHealthPal is a health & wellbeing app to promote healthy living and help you manage your own or other people's health conditions.
Materials Nexus — Accelerating change to net-zero materials